{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-25-001240","form_type":"8-K","ticker":"ARTL","cik":"0001621221","company_name":"ARTELO BIOSCIENCES, INC.","filed_at":"2025-07-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.497873+00:00","generated_at":"2026-05-18T05:44:27.390694+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Artelo Biosciences enters $6.5M at-the-market equity offering with R.F. Lafferty","bullets":["Agreement with R.F. Lafferty & Co. to sell up to $6.5M of common stock via ATM program.","Manager commission: 2.0% of gross sales price per share; Company may set minimum price.","Offering can be suspended by either party on 5 days' notice; Company has no obligation to sell.","Based on existing Form S-3 shelf effective July 14, 2023; prospectus supplement filed July 18, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-25-001240","json":"https://secwatch.observer/filing/0001640334-25-001240.json","markdown":"https://secwatch.observer/filing/0001640334-25-001240.md","text":"https://secwatch.observer/filing/0001640334-25-001240.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621221/000164033425001240/0001640334-25-001240-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621221/000164033425001240/artl_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T05:44:27.390694+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}